DE2240187A1 - Vitamin/hormone ointment - esp for skin disorders - Google Patents

Vitamin/hormone ointment - esp for skin disorders

Info

Publication number
DE2240187A1
DE2240187A1 DE19722240187 DE2240187A DE2240187A1 DE 2240187 A1 DE2240187 A1 DE 2240187A1 DE 19722240187 DE19722240187 DE 19722240187 DE 2240187 A DE2240187 A DE 2240187A DE 2240187 A1 DE2240187 A1 DE 2240187A1
Authority
DE
Germany
Prior art keywords
vitamin
pref
parts
ointment
skin disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19722240187
Other languages
German (de)
Inventor
Jereb Franz Dr Albin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to DE19722240187 priority Critical patent/DE2240187A1/en
Publication of DE2240187A1 publication Critical patent/DE2240187A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63Steroids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/671Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/673Vitamin B group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/676Ascorbic acid, i.e. vitamin C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/678Tocopherol, i.e. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/008Preparations for oily skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/006Antidandruff preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth

Abstract

Ointment contains vitamin A (axerophthol)(pref. 0.45 parts), vitamin B6 (pyridoxine hydrochloride) (pref. 0.25 parts), vitamin C (ascorbic acid) (pref. 1.00 part), vitamin D2 (calciferol) (pref. 0.15 parts), vitamin E (tocopheryl acetate) (pref. 0.30 parts), vitamin K 3 (sodium menadione bisulphite) (pref. 0.05 parts), progesterone (pref. 0.05 parts) and testosterone propionate (pref. 0.025 parts per thousand). It is suitable for the treatment of a variety of eye and skin disorders, including conjuctivitus, belpharitis, acne, psoriasis, seborrhoea, ulcus cruris etc., as well as haemorrhoids, fistulae, pruritis ani, anal fissures, phlegmones, gangrene, bruises, myalgias and muscular rheumatism.

Description

Salbe Die Erfindung betrifft eine Salbe zur Behandlung und Heilung verschiedener Ha@ Krankheiten, insbesondere von Hautkrankheiten0 Viele Hautkrankheiten werden durch funktionelle Störungen der Talg- und Schweißdrüsen hervorgerufen wie beispielsweise die Acne vulgaris, Seborrhöe u.a.m. Zur Behandlung von Hautkrankheiten dienen Maßnahmen, die den Gesamtorganismus beeinflussen wie Diät, Umstimmung (z.B0 Fieber), Vitamine, Hormone, Antibiotika und chemotherapeutische Mittel und örtliche Maßnahmen wie Umschläge, Puder, Pasten, Salben, Schüttelmixturen, Pinselungen mit Tinkturen, Anwendung verschiedener Strahlenarten (ultraviolett, Röntgen).Ointment The invention relates to an ointment for treatment and healing various Ha @ diseases, especially skin diseases0 Many skin diseases are caused by functional disorders of the sebum and sweat glands such as for example acne vulgaris, seborrhea, etc. For the treatment of skin diseases serve measures that affect the entire organism such as diet, change of mood (e.g. 0 Fever), vitamins, hormones, antibiotics and chemotherapeutic agents and local Measures such as envelopes, powder, pastes, ointments, Schüttelmixturen, brushing with Tinctures, application of various types of radiation (ultraviolet, X-ray).

Die erwähnten Behandlungsmethoden zeitigen oft nicht den gewünschten Erfolg oder bringen nur bei ganz bestimmten Hautkrankheiten Erfolge.The treatment methods mentioned often do not produce the desired results Success or only bring success with very specific skin diseases.

Der Erfindung liegt die Aufgabe zugrunde, eine Heilsalbe vorzuschlagen, die bei einer großen Anzahl von Hautkrankheiten Anwendung finden kann, so daß zahlreiche Krankheiten durch eine einfache Salbenbehandlung heilbar sind.The invention is based on the object of proposing a healing ointment, which can find application in a large number of skin diseases, so that numerous Diseases can be cured with a simple ointment treatment.

Die erfindungsgemäße Salbe ist gekennzeichnet durch Arzneimittelanteile aus Vitamin A -Axerophtolum, Vitamin B 6 - Pyridoxin hydrochloridum, Vitamin C - Acidum ascorbicum, Vitamin D 2 -Calciferolum, Vitamin E - Tocopheroli acetas, Vitamin K 3 - Natrii menadiom bisulfis, Progesteron und Testosteroni propioflas. The ointment according to the invention is characterized by pharmaceutical components from vitamin A - axerophtholum, vitamin B 6 - pyridoxine hydrochloridum, vitamin C - Acidum ascorbicum, Vitamin D 2 -Calciferolum, Vitamin E - Tocopheroli acetas, Vitamin K 3 - Natrii menadiom bisulfis, progesterone and Testosteroni propioflas.

Die beste Heilwirkung wird erzielt mit Arzneimittelanteilen von eta 0,5 Vitamin A -Axerophtolum, 0,25 Vitamin B 6-Pyridoxin hydrochloridum, # 1,00 Vitamin C - Acidum ascorbicum, 0,15 Vitamin D 2-Calciferolum, 0,30 Vitamin E -Tocopheroli acetas, 0,05 Vitamin K 3 - Natrii menadiom bisulfis, 0,05 Progesteron, 0,025 Testosteroni propionas Promilleanteilen. The best healing effect is achieved with pharmaceutical components from eta 0.5 vitamin A -Axerophtholum, 0.25 vitamin B 6-pyridoxine hydrochloridum, # 1.00 vitamin C - Acidum ascorbicum, 0.15 vitamin D 2-calciferolum, 0.30 vitamin E -tocopheroli acetas, 0.05 vitamin K 3 - Natrii menadiom bisulfis, 0.05 progesterone, 0.025 testosteroni propionas per mille.

Eine Salbe dieser Zusammensetzung ist insbesondere bei folgenden Krankheiten geeignet: Augenkrankheiten : Cunjuctivitis, Blepharitis, Hordeolum und Chalazion. An ointment of this composition is particularly useful in the following Diseases suitable: eye diseases: cunjuctivitis, blepharitis, hordeolum and Chalazion.

Hauckrankheiten : Hautp @ege, Sommersprossen, Atrophien, Altersfalten, Wwidbehandlung, Verbrennung, Sonnenbrand, Acne vulgaris, Psoriasis vulgaris, Rosacae, alle Arten von Ekzemen, Furunkel, Pityriasis versicolor, Kopfschuppen, Seborrhoischer Haarausfall, Seborrhöe, Ulcus cruris und Decubitus. Skin diseases: skin care, freckles, atrophies, age wrinkles, Wwid treatment, burns, sunburn, acne vulgaris, psoriasis vulgaris, rosacae, all kinds of eczema, boils, pityriasis versicolor, dandruff, seborrheic Hair loss, seborrhea, leg ulcers and decubitus.

Äußere und innere Hämorrhoiden, Fistulae, Pruritus ani, Analfissuren, Phlegmone, Gsanggrene, Prellungen, Myalgien und Muskelrheuma.External and internal hemorrhoids, fistulae, pruritus ani, anal fissures, Phlegmon, Gsanggrene, bruises, myalgias and muscular rheumatism.

In der Regel genügt bei allen diesen Krankheiten ein zlfeimaliger Salbenauftrag pro Tag innerhalb einer Zeit von vier bis acht Wochen.As a rule, one tenfold is sufficient for all of these diseases Ointment application per day within a period of four to eight weeks.

Die beschriebene Heilsalbe verbindet somit die Vorteile der einfachen Salbenbehandlung und einer N mehrfachen Wirksamkeit.The healing ointment described thus combines the advantages of the simple Ointment treatment and an N multiple effectiveness.

Claims (2)

P a t e n t a n s p r ü c h eP a t e n t a n s p r ü c h e 1. Salbe mit Arzneimittelantoilen aus Vitamin A - Axerophtolum, Vitamin B 6 - Pyridoxin hydrochloridum, Vitamin C - Acidum ascorbicum, Vitamin D 2 - Calciferolum, Vitamin E - Tocopheroli acetas, Vitamin K 3 - Natrii menadiom bisulfis, Progesteron, Testosteroni propionas.1. Ointment with medicinal ingredients made from vitamin A - axerophtolum, vitamin B 6 - pyridoxine hydrochloridum, vitamin C - acidum ascorbicum, vitamin D 2 - calciferolum, Vitamin E - Tocopheroli acetas, Vitamin K 3 - Natrii menadiom bisulfis, Progesterone, Testosteroni propionas. 2. Salbe nach Anspruch 1, gekennzeichnet durch etwa 0,45 Vitamin B A - Axerophtolumt 0,25 Vitamin B 6 - Pyridoxin hydrochloridum, 1,00 Vitamin C - Acidum ascorbicum, 0,15 Vitamin D 2 -Calciferelum, 0,30 Vitamin E - Tocopheroli acetas, 0,05 Vitamin K 3 - Natrii menadiom bisulfis, 0,05 Progesteron, 0,025 Testosteroini Propionas Promilleanteilen.2. Ointment according to claim 1, characterized by about 0.45 vitamin B. A - Axerophtolumt 0.25 Vitamin B 6 - Pyridoxine hydrochloridum, 1.00 Vitamin C - Acidum ascorbicum, 0.15 vitamin D 2 - calciferelum, 0.30 vitamin E - tocopheroli acetas, 0.05 vitamin K 3 - Natrii menadiom bisulfis, 0.05 progesterone, 0.025 testosteroini Propionas per mille.
DE19722240187 1972-08-16 1972-08-16 Vitamin/hormone ointment - esp for skin disorders Withdrawn DE2240187A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE19722240187 DE2240187A1 (en) 1972-08-16 1972-08-16 Vitamin/hormone ointment - esp for skin disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19722240187 DE2240187A1 (en) 1972-08-16 1972-08-16 Vitamin/hormone ointment - esp for skin disorders

Publications (1)

Publication Number Publication Date
DE2240187A1 true DE2240187A1 (en) 1974-02-21

Family

ID=5853678

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19722240187 Withdrawn DE2240187A1 (en) 1972-08-16 1972-08-16 Vitamin/hormone ointment - esp for skin disorders

Country Status (1)

Country Link
DE (1) DE2240187A1 (en)

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2385390A1 (en) * 1977-04-01 1978-10-27 Marechal Raymond Topical compsn. for treatment of seborrhoeic alopecia, dandruff, etc. - contains an aromatic cpd. having phenolic or quinone groups and/or a mercury cpd. which inhibits enzyme mercapto groups
EP0001851A1 (en) * 1977-10-29 1979-05-16 Akzo N.V. Highly concentrated pharmaceutical formulations of steroids and processes for their preparation
EP0027987A2 (en) * 1979-10-22 1981-05-06 Eisai Co., Ltd. Composition for treating or preventing psoriasis and delta-tocopherol or ester thereof for use in a topical composition
FR2477871A1 (en) * 1980-03-14 1981-09-18 Gratadour Jean Pierre Compsns. contg. antioxidant, organic acid, and surfactant - to prevent hair loss from hormonal causes
WO1983002390A1 (en) * 1982-01-20 1983-07-21 Henkel Kgaa Sebosuppressive cosmetic products containing long chain alcanols and oxygen inhibitors
EP0129197A2 (en) * 1983-06-20 1984-12-27 Kao Corporation Hair growth promoting composition
EP0129003A2 (en) * 1983-03-22 1984-12-27 Yissum Research Development Company Of The Hebrew University Of Jerusalem Cosmetic and dermatological compositions containing 1-alpha-hydroxycholecalciferol
EP0158090A1 (en) * 1984-03-07 1985-10-16 Roshdy Dr. Ismail Drug for the treatment and the protection of the skin
DE3514724A1 (en) * 1985-04-24 1986-10-30 Albin F. Dr. 4200 Oberhausen Jereb Ointment for the prevention and treatment of disorders of the eyes and skin
EP0202276A1 (en) * 1984-11-02 1986-11-26 Gen Hospital Corp Composition for the treatment of psoriasis.
US4888342A (en) * 1984-05-16 1989-12-19 Kligman Albert M Methods for treatment of sundamaged human skin with retinoids
US5541220A (en) * 1984-03-07 1996-07-30 Ismail; Roshdy Agents for the treatment and protection of the skin
EP0727985A1 (en) * 1993-10-22 1996-08-28 Melvin L. Elson Composition and method for treating blood vessel disorders of the skin using vitamin k
WO2001022959A2 (en) * 1999-09-28 2001-04-05 University Of Pennsylvania Compositions comprising progesterone or progesterone analogs for the treatment of inflammatory conditions
EP1625844A1 (en) * 2003-05-16 2006-02-15 Lotus Pharmaceutical Co., Ltd. The composition for external use by percutaneous administration
EP1889613A1 (en) * 2005-05-27 2008-02-20 Shionogi & Co., Ltd. Pharmaceutical composition comprising vitamin k
US8883856B2 (en) * 2000-02-28 2014-11-11 John Jackson Compositions and methods for the treatment of inflammatory diseases using topoisomerase inhibitors
EP3939561A1 (en) * 2020-07-15 2022-01-19 Najoi Zbida Composition for encouraging hair growth

Cited By (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2385390A1 (en) * 1977-04-01 1978-10-27 Marechal Raymond Topical compsn. for treatment of seborrhoeic alopecia, dandruff, etc. - contains an aromatic cpd. having phenolic or quinone groups and/or a mercury cpd. which inhibits enzyme mercapto groups
EP0001851A1 (en) * 1977-10-29 1979-05-16 Akzo N.V. Highly concentrated pharmaceutical formulations of steroids and processes for their preparation
US4212863A (en) 1977-10-29 1980-07-15 Akzo N.V. Highly concentrated pharmaceutical formulations of steroids and processes for their preparation
DK152721B (en) * 1977-10-29 1988-05-02 Akzo Nv PROCEDURE FOR PREPARING A POWERFUL CONCENTRATED FLUID PHARMACEUTICAL PREPARATION OF A STEROID
EP0027987A2 (en) * 1979-10-22 1981-05-06 Eisai Co., Ltd. Composition for treating or preventing psoriasis and delta-tocopherol or ester thereof for use in a topical composition
EP0027987A3 (en) * 1979-10-22 1982-08-04 Eisai Co., Ltd. Composition for treating or preventing psoriasis and delta-tocopherol or ester thereof for use in a topical composition
FR2477871A1 (en) * 1980-03-14 1981-09-18 Gratadour Jean Pierre Compsns. contg. antioxidant, organic acid, and surfactant - to prevent hair loss from hormonal causes
WO1983002390A1 (en) * 1982-01-20 1983-07-21 Henkel Kgaa Sebosuppressive cosmetic products containing long chain alcanols and oxygen inhibitors
EP0129003A2 (en) * 1983-03-22 1984-12-27 Yissum Research Development Company Of The Hebrew University Of Jerusalem Cosmetic and dermatological compositions containing 1-alpha-hydroxycholecalciferol
EP0129003A3 (en) * 1983-03-22 1985-04-10 Yissum Research And Development Company Of The Hebrew University Of Jerusalem Cosmetic and dermatological compositions containing 1-alpha-hydroxycholecalciferol
EP0129197A3 (en) * 1983-06-20 1986-02-05 Kao Corporation Hair growth promoting composition
EP0129197A2 (en) * 1983-06-20 1984-12-27 Kao Corporation Hair growth promoting composition
EP0158090A1 (en) * 1984-03-07 1985-10-16 Roshdy Dr. Ismail Drug for the treatment and the protection of the skin
US5786384A (en) * 1984-03-07 1998-07-28 Ismail; Roshdy Agents for the treatment and protection of the skin
US5652261A (en) * 1984-03-07 1997-07-29 Ismail; Roshdy Method for the treatment and protection of the skin
US5541220A (en) * 1984-03-07 1996-07-30 Ismail; Roshdy Agents for the treatment and protection of the skin
US4888342A (en) * 1984-05-16 1989-12-19 Kligman Albert M Methods for treatment of sundamaged human skin with retinoids
EP0202276A4 (en) * 1984-11-02 1988-09-28 Gen Hospital Corp Composition for the treatment of psoriasis.
EP0202276A1 (en) * 1984-11-02 1986-11-26 Gen Hospital Corp Composition for the treatment of psoriasis.
DE3514724A1 (en) * 1985-04-24 1986-10-30 Albin F. Dr. 4200 Oberhausen Jereb Ointment for the prevention and treatment of disorders of the eyes and skin
EP0727985A1 (en) * 1993-10-22 1996-08-28 Melvin L. Elson Composition and method for treating blood vessel disorders of the skin using vitamin k
EP0727985A4 (en) * 1993-10-22 1997-07-02 Melvin L Elson Composition and method for treating blood vessel disorders of the skin using vitamin k
WO2001022959A3 (en) * 1999-09-28 2001-10-04 Univ Pennsylvania Compositions comprising progesterone or progesterone analogs for the treatment of inflammatory conditions
WO2001022959A2 (en) * 1999-09-28 2001-04-05 University Of Pennsylvania Compositions comprising progesterone or progesterone analogs for the treatment of inflammatory conditions
JP2003510277A (en) * 1999-09-28 2003-03-18 ユニバーシティー オブ ペンシルバニア Treatment of inflammation with progesterone or progesterone analog
US6610674B1 (en) 1999-09-28 2003-08-26 University Of Pennsylvania Method of treating inflammatory conditions with progesterone analogs
US8883856B2 (en) * 2000-02-28 2014-11-11 John Jackson Compositions and methods for the treatment of inflammatory diseases using topoisomerase inhibitors
EP1625844A1 (en) * 2003-05-16 2006-02-15 Lotus Pharmaceutical Co., Ltd. The composition for external use by percutaneous administration
EP1625844A4 (en) * 2003-05-16 2009-05-13 Lotus Pharmaceutical Co Ltd The composition for external use by percutaneous administration
EP1889613A1 (en) * 2005-05-27 2008-02-20 Shionogi & Co., Ltd. Pharmaceutical composition comprising vitamin k
EP1889613A4 (en) * 2005-05-27 2010-11-24 Shionogi & Co Pharmaceutical composition comprising vitamin k
EP3939561A1 (en) * 2020-07-15 2022-01-19 Najoi Zbida Composition for encouraging hair growth

Similar Documents

Publication Publication Date Title
DE2240187A1 (en) Vitamin/hormone ointment - esp for skin disorders
DE3514724C2 (en)
AT406731B (en) SUBSTANCE MIXTURE FOR TOPICAL APPLICATION
EP0435913B1 (en) Effervescent tablet
DE1902227A1 (en) Medicines for psychotherapeutic use and processes for their manufacture
DE4239959A1 (en) St. John's wort dry extract, process for its preparation and its use
EP0209724B1 (en) Preparation effective against acne and the use of an active extract of couch grass
JP6400851B2 (en) Pharmaceutical composition for acne removal and method for producing the same
EP1131063B1 (en) Hyperforin ointment or cream
DE19547317A1 (en) Antiviral drug
DE69927260T2 (en) TOPICAL PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF SKIN OR CIRCULATORY DISEASES OF INFLAMMATORY, IMMUNE, PROLIFERATIVE OR DEGENERATIVE BASIS
EP0198172B1 (en) Pharmaceutical preparation
EP0679395A1 (en) Pharmaceutical compositions containing a ketoprofen solution in a soft gelatine capsule and method to produce them
EP0151987B1 (en) Means for the treatment of diseases of the veins and the anal region
DE4028945A1 (en) KAWA-KAWA EXTRACT, METHOD FOR PRODUCING IT AND ITS USE
DE3315463A1 (en) Pharmaceutical compositions for the topical treatment of psoriasis
DE3590001T1 (en) Oral drugs for the treatment or prevention of acne
DE3901286A1 (en) Hair tonic with vegetable hypertonics
KR20130030013A (en) Skin external composition containing a polysaccharide of grifola frondosa and the method preparing thereof
DE2460205A1 (en) Anti-dermatomycosis medicaments - contg hinokitiol, undecylic acid, and thymol
DE10247339A1 (en) Composition, useful in the treatment of psoriasis, comprises e.g., Gan Jiang (dried ginger), Dan Shen (Danshen root/red sage) and Jiang Xiang (rosewood heart wood)
EP3741378A1 (en) Topical composition for the treatment and care of psoriatic skin
DE2243320C2 (en) Medicines based on compounds containing iodine and anti-inflammatory corticosteroids
EP0344820B1 (en) Means for the treatment of cardiac diseases
Izzedine et al. Vergleichende Serumuntersuchungen über Verhalten und Bedeutung von Autoantikörpern und Fermentaktivität bei Leberkrankheiten

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee